AstraZeneca Canada Inc.
AstraZeneca is a science-led biopharmaceutical company pushing the boundaries of science to deliver life-changing medicines. The company employs roughly 900 people in Canada who work to research, develop and market innovative medicines. AstraZeneca Canada was recently designated a global Clinical Hub for oncology and immuno-oncology clinical studies. We are currently leading global oncology clinical studies in lung, head and neck cancer.
The future of treatment for many of today’s diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. Our focus is on the following core therapy areas: Cardiovascular, Renal and Metabolic diseases (CVRM); Oncology; and Respiratory & Immunology. AstraZeneca has 64,000 employees world wide and 11 research centres in 7 countries.
Global Pharmaceutical Corporations
- Cardiovascular Disease
- Infectious Diseases
- Metabolic Diseases
- Neurological Diseases